• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利拉鲁肽在 Gato-Kakizaki 大鼠早期干预中保护胰岛β细胞。

Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.

机构信息

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Diabetes. 2013 Dec;5(4):421-8. doi: 10.1111/1753-0407.12061. Epub 2013 Jun 4.

DOI:10.1111/1753-0407.12061
PMID:23590680
Abstract

BACKGROUND

Glucagon-like peptide-1 (GLP-1) analogues have emerged as insulin secretagogues and are widely used in type 2 diabetic patients. GLP-1 analogues also demonstrate a promotion of beta cell proliferation and reduction of apoptosis in rodents. In the present study, we investigated the protection of pancreatic beta cells by early use (at the age of 2 weeks) of GLP-1 analogue, liraglutide in Gato-Kakizaki (GK) rats and explored the underlying mechanisms.

METHODS

The effects of liraglutide on glucose tolerance were evaluated by intraperitoneal glucose tolerance test (IPGTT) and insulin release tests (IRT). Ki67 and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) immunostaining, Western blots and real-time polymerase chain reaction were applied to evaluate cell proliferation, apoptosis and related gene expressions.

RESULTS

Our results demonstrated that early use of liraglutide improved glucose tolerance during liraglutide treatment in GK rats. Liraglutide increased pancreatic insulin contents and markedly reduced beta cell apoptosis. Liraglutide also downregulated pro-apoptotic gene expressions and reduced intra-islet macrophage infiltration.

CONCLUSIONS

This experiment reported for the first time that early use of liraglutide could protect beta cell failure in pre-diabetic GK rats through reduction of beta cell apoptosis and ameliorating islet inflammation.

摘要

背景

胰高血糖素样肽-1(GLP-1)类似物已成为胰岛素促分泌剂,广泛应用于 2 型糖尿病患者。GLP-1 类似物还能促进啮齿动物β细胞增殖,减少细胞凋亡。在本研究中,我们研究了在 Gato-Kakizaki(GK)大鼠中早期使用 GLP-1 类似物利拉鲁肽对胰岛β细胞的保护作用,并探讨了其潜在机制。

方法

通过腹腔内葡萄糖耐量试验(IPGTT)和胰岛素释放试验(IRT)评估利拉鲁肽对葡萄糖耐量的影响。Ki67 和末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)免疫染色、Western blot 和实时聚合酶链反应用于评估细胞增殖、细胞凋亡和相关基因表达。

结果

我们的结果表明,在 GK 大鼠中,早期使用利拉鲁肽可改善利拉鲁肽治疗期间的葡萄糖耐量。利拉鲁肽增加了胰腺胰岛素含量,并显著减少了β细胞凋亡。利拉鲁肽还下调了促凋亡基因的表达,并减少了胰岛内巨噬细胞浸润。

结论

本实验首次报道,早期使用利拉鲁肽可通过减少β细胞凋亡和改善胰岛炎症来保护糖尿病前期 GK 大鼠的β细胞衰竭。

相似文献

1
Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.利拉鲁肽在 Gato-Kakizaki 大鼠早期干预中保护胰岛β细胞。
J Diabetes. 2013 Dec;5(4):421-8. doi: 10.1111/1753-0407.12061. Epub 2013 Jun 4.
2
Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.利拉鲁肽早期干预可改善年轻的Goto-Kakizaki大鼠的糖耐量,而不影响其胰岛微循环。
Regul Pept. 2012 Aug 20;177(1-3):92-6. doi: 10.1016/j.regpep.2012.05.091. Epub 2012 May 12.
3
The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.人胰高血糖素样肽-1 类似物利拉鲁肽通过 AMPK/mTOR/P70S6K 信号通路调节胰岛β细胞增殖和凋亡。
Peptides. 2013 Jan;39:71-9. doi: 10.1016/j.peptides.2012.10.006. Epub 2012 Oct 30.
4
Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.长期利拉鲁肽治疗与 ZDF 大鼠β细胞中胰岛素含量和分泌增加以及α细胞丢失有关。
Pharmacol Res. 2013 Oct;76:58-66. doi: 10.1016/j.phrs.2013.07.005. Epub 2013 Jul 26.
5
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.利拉鲁肽是一种长效人胰高血糖素样肽1类似物,可改善小鼠边缘质量胰岛移植中的葡萄糖稳态。
Endocrinology. 2008 Sep;149(9):4322-8. doi: 10.1210/en.2008-0501. Epub 2008 May 29.
6
Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.利拉鲁肽可改善四氧嘧啶诱导的糖尿病小鼠的胰腺β细胞质量和功能。
PLoS One. 2015 May 4;10(5):e0126003. doi: 10.1371/journal.pone.0126003. eCollection 2015.
7
Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.利拉鲁肽,一种人胰高血糖素样肽-1 类似物,可刺激 AKT 依赖性生存信号转导并抑制胰岛β细胞凋亡。
J Cell Mol Med. 2018 Jun;22(6):2970-2980. doi: 10.1111/jcmm.13259. Epub 2018 Mar 10.
8
Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.新型胰高血糖素样肽-1(GLP-1)类似物(Val8)GLP-1在肥胖糖尿病(ob/ob)小鼠中每日给药3周后,可显著改善糖耐量和胰腺β细胞功能。
J Pharmacol Exp Ther. 2006 Aug;318(2):914-21. doi: 10.1124/jpet.105.097824. Epub 2006 Apr 28.
9
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.特索格列净,一种新型人源每周一次 GLP-1 类似物,可在体外保护胰岛 β 细胞,并在体内保护 Zucker 糖尿病肥胖大鼠的胰岛结构和功能。
Diabetes Obes Metab. 2011 Apr;13(4):326-36. doi: 10.1111/j.1463-1326.2010.01352.x.
10
Early liraglutide treatment is better in glucose control, β-cell function improvement and mass preservation in db/db mice.早期利拉鲁肽治疗在db/db小鼠的血糖控制、β细胞功能改善和质量维持方面效果更佳。
Peptides. 2014 Feb;52:134-42. doi: 10.1016/j.peptides.2013.11.011. Epub 2014 Jan 7.

引用本文的文献

1
Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China.在中国德谷胰岛素利拉鲁肽进入国家医保药品目录后,与基础胰岛素加用胰高血糖素样肽-1受体激动剂(GLP-1RA)相比,德谷胰岛素利拉鲁肽治疗2型糖尿病患者的长期成本效益分析
PLoS One. 2025 Feb 6;20(2):e0310497. doi: 10.1371/journal.pone.0310497. eCollection 2025.
2
Evidence for a Pro-Inflammatory State of Macrophages from Non-Obese Type-2 Diabetic Goto-Kakizaki Rats.非肥胖 2 型糖尿病 Goto-Kakizaki 大鼠巨噬细胞的促炎状态证据。
Int J Mol Sci. 2024 Sep 24;25(19):10240. doi: 10.3390/ijms251910240.
3
Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology.
运用miRNA组学技术探究利拉鲁肽对2型糖尿病大鼠胰岛功能的影响及作用靶点
Diabetes Metab Syndr Obes. 2021 Sep 1;14:3795-3807. doi: 10.2147/DMSO.S325030. eCollection 2021.
4
Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.2型糖尿病易患情况下β细胞凋亡的机制及基于胰高血糖素样肽-1疗法的潜在保护作用
Int J Mol Sci. 2021 May 18;22(10):5303. doi: 10.3390/ijms22105303.
5
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.在葡萄糖耐量受损或新近诊断的 2 型糖尿病成人中停止药物干预后,β 细胞功能无持久改善。
Diabetes Care. 2019 Sep;42(9):1742-1751. doi: 10.2337/dc19-0556. Epub 2019 Jun 9.
6
Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto-Kakizaki rats.肠道电刺激可减轻 2 型糖尿病 Goto-Kakizaki 大鼠的高血糖,并防止胰岛 β 细胞丢失。
Nutr Diabetes. 2019 Feb 6;9(1):4. doi: 10.1038/s41387-019-0072-2.
7
Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome.利拉鲁肽预防性治疗可预防沃尔弗拉姆综合征大鼠模型葡萄糖不耐受的发展。
Sci Rep. 2018 Jul 5;8(1):10183. doi: 10.1038/s41598-018-28314-z.
8
A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).胰高血糖素样肽-1类似物利拉鲁肽与甘精胰岛素对内皮功能和代谢参数影响的比较:一项随机对照试验——札幌动脉粥样硬化肠促胰岛素研究2(SAIS2)
PLoS One. 2015 Aug 18;10(8):e0135854. doi: 10.1371/journal.pone.0135854. eCollection 2015.